Surprisingly, specific attenuation of the IGF-IR function by low molecular weight IGF-IR tyrosine kinase inhibitor, NVP-AEW541, had only modest effects on Glioma cell motility in serum stimulated LN-229 cells, and had practically no effect on T98G cells. Here, IGF1R is linked to central nervous system cancer.